Citigroup Issues Pessimistic Forecast for H. B. Fuller (NYSE:FUL) Stock Price

Key Points

• Citigroup has cut its price target for H. B. Fuller from $70.00 to $62.00, indicating a "neutral" rating for the stock, which suggests a potential upside of 8.57% from its previous close.
• Various analysts have differing views on H. B. Fuller, with targets varying from $50.00 to $75.00, and a consensus average target price of $65.75.
• In the latest earnings report, H. B. Fuller exceeded EPS expectations with $1.26, but revenue fell 2.8% compared to the previous year, amounting to $892.04 million.

H. B. Fuller (NYSE:FUL - Get Free Report) had its price objective cut by Citigroup from $70.00 to $62.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a "neutral" rating on the specialty chemicals company's stock. Citigroup's price objective would suggest a potential upside of 8.57% from the company's previous close.

A number of other analysts also recently issued reports on FUL. JPMorgan Chase & Co. raised their price target on shares of H. B. Fuller from $50.00 to $54.00 and gave the company an "underweight" rating in a report on Friday, June 27th. Robert W. Baird increased their price target on H. B. Fuller from $60.00 to $75.00 and gave the company an "outperform" rating in a report on Friday, June 27th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $65.75.

H. B. Fuller Price Performance

Shares of FUL opened at $57.11 on Friday. The firm has a 50 day moving average of $59.71 and a 200 day moving average of $57.20. The company has a quick ratio of 1.15, a current ratio of 1.87 and a debt-to-equity ratio of 1.13. H. B. Fuller has a twelve month low of $47.56 and a twelve month high of $82.39. The company has a market capitalization of $3.08 billion, a P/E ratio of 27.32, a price-to-earnings-growth ratio of 0.98 and a beta of 1.14.

H. B. Fuller (NYSE:FUL - Get Free Report) last posted its quarterly earnings results on Wednesday, September 24th. The specialty chemicals company reported $1.26 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.02. H. B. Fuller had a return on equity of 11.50% and a net margin of 2.92%.The firm had revenue of $892.04 million during the quarter, compared to analysts' expectations of $894.60 million. During the same quarter in the previous year, the business earned $1.13 earnings per share. The company's revenue was down 2.8% on a year-over-year basis. H. B. Fuller has set its FY 2025 guidance at 4.100-4.250 EPS. As a group, equities research analysts anticipate that H. B. Fuller will post 4.07 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, VP Joao Magalhaes sold 1,099 shares of the stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $56.31, for a total value of $61,884.69. Following the completion of the sale, the vice president directly owned 3,285 shares of the company's stock, valued at approximately $184,978.35. This represents a 25.07% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Robert J. Martsching sold 9,546 shares of the firm's stock in a transaction that occurred on Thursday, July 10th. The stock was sold at an average price of $64.30, for a total transaction of $613,807.80. Following the sale, the vice president owned 14,980 shares in the company, valued at approximately $963,214. The trade was a 38.92% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 11,691 shares of company stock valued at $734,478. 1.99% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. Parallel Advisors LLC raised its holdings in H. B. Fuller by 141.6% during the second quarter. Parallel Advisors LLC now owns 534 shares of the specialty chemicals company's stock valued at $32,000 after acquiring an additional 313 shares during the period. EverSource Wealth Advisors LLC raised its stake in H. B. Fuller by 129.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,218 shares of the specialty chemicals company's stock valued at $73,000 after purchasing an additional 688 shares during the period. Smartleaf Asset Management LLC raised its stake in H. B. Fuller by 44.4% during the 2nd quarter. Smartleaf Asset Management LLC now owns 1,307 shares of the specialty chemicals company's stock valued at $81,000 after purchasing an additional 402 shares during the period. Signaturefd LLC lifted its holdings in H. B. Fuller by 20.5% in the 2nd quarter. Signaturefd LLC now owns 1,743 shares of the specialty chemicals company's stock worth $105,000 after purchasing an additional 297 shares in the last quarter. Finally, Strs Ohio bought a new position in H. B. Fuller in the 1st quarter worth approximately $101,000. Institutional investors own 95.93% of the company's stock.

About H. B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.